Insight: For a long time, MS treatments were either administered by IV or subcutaneous injection. Because Tecfidera was only the second disease modifying treatment available in a pill, many people living with MS were convinced it would be effective at controlling their relapses or disease progression.

What if: We could get our audience excited about getting the same benefits as an IV or SubQ treatment, but from a PILL and get them to completely reimagine MS treatments?